Is PAVmed Stock a Good Investment?
PAVmed Investment Advice | PAVM |
- Examine PAVmed's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research PAVmed's leadership team and their track record. Good management can help PAVmed navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact PAVmed's business and its evolving consumer preferences.
- Compare PAVmed's performance and market position to its competitors. Analyze how PAVmed is positioned in terms of product offerings, innovation, and market share.
- Check if PAVmed pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about PAVmed's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in PAVmed Inc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if PAVmed Inc is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Abnormally volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine PAVmed Stock
Researching PAVmed's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 15.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.14. PAVmed Inc had not issued any dividends in recent years. The entity had 1:15 split on the 7th of December 2023.
To determine if PAVmed is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding PAVmed's research are outlined below:
| PAVmed Inc is way too risky over 90 days horizon | |
| PAVmed Inc has some characteristics of a very speculative penny stock | |
| PAVmed Inc appears to be risky and price may revert if volatility continues | |
| PAVmed Inc has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 2.45 M. Net Loss for the year was (64.17 M) with loss before overhead, payroll, taxes, and interest of (3.24 M). | |
| PAVmed Inc currently holds about 68.47 M in cash with (52.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75. | |
| PAVmed Inc has a poor financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health Services Forum |
PAVmed uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in PAVmed Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to PAVmed's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of March 2024 Upcoming Quarterly Report | View | |
| 21st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact PAVmed's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises PAVmed's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2020-11-06 | 2020-09-30 | -0.1 | -0.11 | -0.01 | 10 | ||
2016-08-12 | 2016-06-30 | -0.09 | -0.1 | -0.01 | 11 | ||
2023-11-13 | 2023-09-30 | -0.14 | -0.16 | -0.02 | 14 | ||
2021-11-22 | 2021-09-30 | -0.13 | -0.15 | -0.02 | 15 | ||
2020-05-21 | 2020-03-31 | -0.11 | -0.13 | -0.02 | 18 | ||
2019-05-15 | 2019-03-31 | -0.13 | -0.11 | 0.02 | 15 | ||
2017-05-22 | 2017-03-31 | -0.14 | -0.16 | -0.02 | 14 | ||
2022-11-14 | 2022-09-30 | -0.26 | -0.29 | -0.03 | 11 |
Know PAVmed's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as PAVmed is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PAVmed Inc backward and forwards among themselves. PAVmed's institutional investor refers to the entity that pools money to purchase PAVmed's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Tower Research Capital Llc | 2024-06-30 | 9.7 K | Ubs Group Ag | 2024-06-30 | 4.8 K | Cwm, Llc Duplicate | 2024-06-30 | 4.7 K | Wells Fargo & Co | 2024-06-30 | 3.9 K | Atlantic Trust Group, Llc | 2024-06-30 | 836 | Hanson Mcclain Inc | 2024-09-30 | 447 | Advisor Group Holdings, Inc. | 2024-06-30 | 116 | Bank Of America Corp | 2024-06-30 | 79.0 | Parallel Advisors, Llc | 2024-06-30 | 78.0 | First Manhattan Co. Llc | 2024-09-30 | 600 K | Vanguard Group Inc | 2024-09-30 | 281 K |
PAVmed's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.74 M.Market Cap |
|
PAVmed's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.02) | (2.13) | |
| Return On Capital Employed | 3.27 | 3.10 | |
| Return On Assets | (1.94) | (2.03) | |
| Return On Equity | 1.19 | 1.13 |
Determining PAVmed's profitability involves analyzing its financial statements and using various financial metrics to determine if PAVmed is a good buy. For example, gross profit margin measures PAVmed's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of PAVmed's profitability and make more informed investment decisions.
Evaluate PAVmed's management efficiency
PAVmed Inc has return on total asset (ROA) of (0.8007) % which means that it has lost $0.8007 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (13.5806) %, meaning that it created substantial loss on money invested by shareholders. PAVmed's management efficiency ratios could be used to measure how well PAVmed manages its routine affairs as well as how well it operates its assets and liabilities. As of the 24th of November 2024, Return On Tangible Assets is likely to drop to -2.13. In addition to that, Return On Capital Employed is likely to drop to 3.10. At this time, PAVmed's Non Current Assets Total are very stable compared to the past year. As of the 24th of November 2024, Asset Turnover is likely to grow to 0.08, while Total Assets are likely to drop about 23.6 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (3.32) | (3.16) | |
| Tangible Book Value Per Share | (3.52) | (3.34) | |
| Enterprise Value Over EBITDA | (0.78) | (0.82) | |
| Price Book Value Ratio | (0.55) | (0.58) | |
| Enterprise Value Multiple | (0.78) | (0.82) | |
| Price Fair Value | (0.55) | (0.58) | |
| Enterprise Value | 58.9 M | 62 M |
The leadership approach at PAVmed's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Beta 0.693 |
Basic technical analysis of PAVmed Stock
As of the 24th of November, PAVmed holds the Mean Deviation of 5.5, coefficient of variation of 944.32, and Market Risk Adjusted Performance of (0.99). Concerning fundamental indicators, the technical analysis model allows you to check practical technical drivers of PAVmed, as well as the relationship between them. Please check PAVmed Inc jensen alpha and downside variance to decide if PAVmed Inc is priced more or less accurately, providing market reflects its current price of 1.0 per share. Given that PAVmed is a hitting penny stock territory we advise to closely look at its total risk alpha.PAVmed's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific PAVmed insiders, such as employees or executives, is commonly permitted as long as it does not rely on PAVmed's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases PAVmed insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
PAVmed's Outstanding Corporate Bonds
PAVmed issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. PAVmed Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most PAVmed bonds can be classified according to their maturity, which is the date when PAVmed Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand PAVmed's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing PAVmed's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0903 | |||
| Market Risk Adjusted Performance | (0.99) | |||
| Mean Deviation | 5.5 | |||
| Semi Deviation | 5.68 | |||
| Downside Deviation | 6.4 | |||
| Coefficient Of Variation | 944.32 | |||
| Standard Deviation | 8.73 | |||
| Variance | 76.23 | |||
| Information Ratio | 0.0909 | |||
| Jensen Alpha | 1.02 | |||
| Total Risk Alpha | (0.46) | |||
| Sortino Ratio | 0.1241 | |||
| Treynor Ratio | (1.00) | |||
| Maximum Drawdown | 63.57 | |||
| Value At Risk | (8.93) | |||
| Potential Upside | 9.46 | |||
| Downside Variance | 40.9 | |||
| Semi Variance | 32.29 | |||
| Expected Short fall | (6.59) | |||
| Skewness | 2.2 | |||
| Kurtosis | 9.78 |
| Risk Adjusted Performance | 0.0903 | |||
| Market Risk Adjusted Performance | (0.99) | |||
| Mean Deviation | 5.5 | |||
| Semi Deviation | 5.68 | |||
| Downside Deviation | 6.4 | |||
| Coefficient Of Variation | 944.32 | |||
| Standard Deviation | 8.73 | |||
| Variance | 76.23 | |||
| Information Ratio | 0.0909 | |||
| Jensen Alpha | 1.02 | |||
| Total Risk Alpha | (0.46) | |||
| Sortino Ratio | 0.1241 | |||
| Treynor Ratio | (1.00) | |||
| Maximum Drawdown | 63.57 | |||
| Value At Risk | (8.93) | |||
| Potential Upside | 9.46 | |||
| Downside Variance | 40.9 | |||
| Semi Variance | 32.29 | |||
| Expected Short fall | (6.59) | |||
| Skewness | 2.2 | |||
| Kurtosis | 9.78 |
Consider PAVmed's intraday indicators
PAVmed intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of PAVmed stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
PAVmed time-series forecasting models is one of many PAVmed's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary PAVmed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
PAVmed Stock media impact
Far too much social signal, news, headlines, and media speculation about PAVmed that are available to investors today. That information is available publicly through PAVmed media outlets and privately through word of mouth or via PAVmed internal channels. However, regardless of the origin, that massive amount of PAVmed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of PAVmed news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of PAVmed relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to PAVmed's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive PAVmed alpha.
PAVmed Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards PAVmed can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
PAVmed Corporate Management
| Michael Gordon | General VP | Profile | |
| Deepika Lakhani | Chief VP | Profile | |
| Lishan MD | Chairman CEO | Profile | |
| Michael Parks | Vice Relations | Profile | |
| Adrian Miller | VP Relations | Profile | |
| Brian MD | Chief Affairs | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.14) | Revenue Per Share 0.459 | Quarterly Revenue Growth 4.898 | Return On Assets (0.80) | Return On Equity (13.58) |
The market value of PAVmed Inc is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed's value that differs from its market value or its book value, called intrinsic value, which is PAVmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed's market value can be influenced by many factors that don't directly affect PAVmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between PAVmed's value and its price, as these two are different measures arrived at by various means. Investors typically determine if PAVmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.